From the Guidelines
Lenvima can cause sun sensitivity, and patients taking this medication should take precautions to protect themselves from sunlight. When considering the potential side effects of Lenvima, it is essential to prioritize morbidity, mortality, and quality of life. Although the provided study 1 does not directly address the relationship between Lenvima and sun sensitivity, it discusses the importance of managing skin-related side effects in cancer treatment. Some key points to consider when taking Lenvima include:
- Wearing protective clothing and broad-spectrum sunscreen with SPF 30 or higher when exposed to sunlight
- Wearing sunglasses and limiting sun exposure, especially during peak hours (10 AM to 4 PM)
- Being aware of the potential for severe skin reactions, such as sunburns, rashes, or skin inflammation, and contacting a healthcare provider immediately if these occur It is crucial to follow these guidelines to minimize the risk of sun sensitivity and other skin-related side effects associated with Lenvima treatment.
From the Research
Lenvima and Sun Sensitivity
- There is limited direct evidence on whether Lenvima causes sun sensitivity.
- However, a study published in the American journal of ophthalmology case reports 2 reports a patient who developed photosensitivity while being treated with lenvatinib and pembrolizumab for metastatic endometrial carcinoma.
- Other studies have reported adverse events associated with lenvatinib, including hypertension, diarrhea, fatigue, and decreased appetite 3, 4, 5, 6, but do not specifically mention sun sensitivity.
- It is worth noting that lenvatinib is a multikinase inhibitor that can cause a range of side effects, and patients taking this medication should be closely monitored for any adverse reactions.